Navigation Links
Chronic pain: Watch out before accepting diagnosis and treatment
Date:9/8/2011

Bethesda, MDA new commentary published online in The FASEB Journal (http://www.fasebj.org) argues that patients should be diligent and demand proof of safety and benefit before beginning any treatment regimen for chronic pain, as some treatments have very little scientific evidence that they actually alleviate the conditions for which they are prescribed. In the article, Phillip J. Baker, Ph.D., Executive Director of the American Lyme Disease Foundation, dispels myths surrounding chronic Lyme disease, using it as an example of why patients should ensure that diagnostic and treatment tools are approved by the Food and Drug Administration and not just recommended by other patients and physicians.

"Despite repeated warnings by the Centers for Disease Control and Prevention and the Food and Drug Administration, the diagnosis of chronic Lyme disease often is based on the false results of non-standard test procedures, not approved by the FDA," said Baker. "This is inexcusable since 46 FDA-approved tests are available and used routinely by various state public health laboratories. A false diagnosis can result in patients being placed on prolonged antibiotic therapy or some other unproven and potentially harmful remedy."

Baker also says that before agreeing to undergo any treatment regimen for chronic pain, patients should ask their physician to provide results from published, placebo-controlled studies proving that the proposed remedy is both beneficial and safe. Testimonials by previously treated patientsregardless of the numberare not sufficient proof of benefit and safety. Unapproved and undocumented treatments are usually not covered by health insurance and therefore result in a huge financial burden to the patient. Chronic Lyme disease must be considered as part of a broad-based, multidisciplinary effort to understand the cause and treatment of chronic pain in general as outlined by the Institute of Med
'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Vitamin E shows possible promise in easing chronic inflammation
2. New research lights up chronic bacterial infection inside bone
3. When acute hepatitis develops into chronic hepatitis
4. Research uncovers promising target to treat chronic abdominal pain
5. New trigger for chronic inflammation in rheumatoid arthritis discovered
6. Early-life experience linked to chronic diseases later in life: UBC research
7. NHLBI awards $11 million for molecular roadmap to chronic lung diseases
8. New potential to treat chronic obstructive pulmonary disease
9. Higher opioid dose linked to overdose risk in chronic pain patients
10. Discovery of new type of immune cells regulating inflammation in chronic diseases
11. New data on highly effective treatment for chronic rhinosinusitis with nasal polyps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial Services ... in the Health and Fitness Industry, today announced ... to MYiCLUBonline.  The latest upgrade includes advances to ... of cardless check-in via Identity One fingerprint biometrics. ... time through interactive displays at the International Health, ...
(Date:2/19/2015)... .19, 2015 Research and Markets ... the "Military Electro-Optical / Infrared Systems Market ... Platform - Forecast to 2020" report to ... systems market is expected to reach $16.35 billion ... This report segments the military electro-optical/infrared ...
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... of glasses of wine each day has generally been considered a ... new Rutgers University study indicates that there is a fine line ... decrease the making of adult brain cells by as much as ... Neuroscience , scheduled to be published on November 8, lead ...
... Mass., Sept. 21, 2012 Aware, Inc. (NASDAQ: ... the sale (as previously announced on August 23, 2012) ... LLC for US $16,000,000.00.  The patents and patent applications ... our patent management operation,s efforts to sell and/or license ...
... driving force behind key discoveries in medicine and biology. ... provides important markers and guidelines for medical diagnostics and ... the cost and speed of obtaining highly accurate DNA ... last 10 years, most current high-throughput sequencing instruments depend ...
Cached Biology News:Moderate drinking decreases number of new brain cells 2Aware Announces Closing Of Sale Of Selected Patents 2Aware Announces Closing Of Sale Of Selected Patents 3Columbia researchers report novel approach for single molecule electronic DNA sequencing 2Columbia researchers report novel approach for single molecule electronic DNA sequencing 3
(Date:3/3/2015)... , March 3, 2015  RegeneRx Biopharmaceuticals, Inc. ... in the scientific journal, Expert Opinion on Biological ... colleague, Dr. Zhenggang Zhang , at the Henry ... reported that Thymosin beta 4 (TB4) has the capacity ... 24 hours or more post-injury, leading to neurological recovery ...
(Date:3/3/2015)... 2015 AtheroNova Inc. (OTCQB: AHRO) today announced that ... petitions under Chapter 11 of the U.S. Bankruptcy Code in ... , Santa Ana division (the ... cases are expected to be jointly administered. The ... asset sale process, for all or substantially all of its ...
(Date:3/3/2015)... Genedata, a leading provider of advanced ... research, today announced that Pfizer Inc. has licensed ... at Pfizer biopharma research and development sites in ... global deployment and roll out project at Pfizer’s ... (CTI), and Pharmaceutical Sciences groups. , “Pfizer ...
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/qcdj5m/rnai ) has ... "RNAi - Technologies, Markets and Companies" to their ... to silence any gene once the sequence is known, ... discriminate gene function. After the genome of an organism ... gene in the genome and target for specific phenotypes. ...
Breaking Biology Technology:Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 2Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 3
... LIUZHOU CITY, Guangxi, China , May 21 ... ("China BCT" or the,"Company"), a leading pharmaceutical distributor, retail pharmacy, ... China , today,announced results for the first quarter ended ... Quarter 2010 Highlights, -- Revenue increased 5.2% ...
... May 21 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ... available on the American Society of Clinical Oncology (ASCO) website at ... research is scheduled to be presented at the ASCO 2010 Annual Meeting ... , , ...
... Inc. (Nasdaq: ITMN ) today announced that Steve Porter , M.D., ... present at the 2010 Citi Health Care Conference in New York ... , , ... presentation, investors and other interested parties may log on to the investor relations ...
Cached Biology Technology:China BCT Reports First Quarter 2010 Results 2China BCT Reports First Quarter 2010 Results 3China BCT Reports First Quarter 2010 Results 4China BCT Reports First Quarter 2010 Results 5China BCT Reports First Quarter 2010 Results 6China BCT Reports First Quarter 2010 Results 7China BCT Reports First Quarter 2010 Results 8China BCT Reports First Quarter 2010 Results 9China BCT Reports First Quarter 2010 Results 10China BCT Reports First Quarter 2010 Results 11China BCT Reports First Quarter 2010 Results 12China BCT Reports First Quarter 2010 Results 13China BCT Reports First Quarter 2010 Results 14Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting 2Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting 3Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting 4InterMune to Present at 2010 Citi Health Care Conference 2
... Microdissection , CapSure HS and CapSure Macro ... extraction of populations of pure cells from ... Capture Microdissection., Ensure the Integrity of ... All CapSure LCM Caps have a patented ...
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)...
... sensitive laser confocal systems designed for rapid ... that meet your expectations, differentiating between a ... the signal on the bottom as well ... for increased sensitivity. Results with VersArray ChipReader ...
Bio-Plex Manager software, version 3.0, 5 license netshare, is a five-user software package that provides access to data from the Bio-Plex suspension array system from a server. This version does not...
Biology Products: